NCT07290569Phase 2Active not recruiting

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

Study sponsor: Oruka Therapeutics, Inc. · ORKA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-10-21Actual
Enrollment · participants160Estimated
Source updated2026-11-06Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Jun 2027. After: 21 Oct 2026.

Check registry source

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source